Literature DB >> 29936620

Switching from CLSI to EUCAST XL susceptibility breakpoint: its implication in urinary tract infection in men.

Amaia Aguirre-Quiñonero1, M C Lecaroz Agara2, A Canut Blasco2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29936620     DOI： 10.1007/s10096-018-3307-6

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  8 in total

Review 1.  CLINICAL PRACTICE. Urinary Tract Infections in Older Men.

Authors:  Anthony J Schaeffer; Lindsay E Nicolle
Journal:  N Engl J Med       Date:  2016-02-11       Impact factor: 91.245

Review 2.  International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases.

Authors:  Kalpana Gupta; Thomas M Hooton; Kurt G Naber; Björn Wullt; Richard Colgan; Loren G Miller; Gregory J Moran; Lindsay E Nicolle; Raul Raz; Anthony J Schaeffer; David E Soper
Journal:  Clin Infect Dis       Date:  2011-03-01       Impact factor: 9.079

3.  MIC of amoxicillin/clavulanate according to CLSI and EUCAST: discrepancies and clinical impact in patients with bloodstream infections due to Enterobacteriaceae.

Authors:  Mercedes Delgado-Valverde; Adoración Valiente-Mendez; Eva Torres; Benito Almirante; Silvia Gómez-Zorrilla; Nuria Borrell; Ana Isabel Aller-García; Mercedes Gurgui; Manel Almela; Mercedes Sanz; Germán Bou; Luis Martínez-Martínez; Rafael Cantón; Jose Antonio Lepe; Manuel Causse; Belén Gutiérrez-Gutiérrez; Álvaro Pascual; Jesús Rodríguez-Baño
Journal:  J Antimicrob Chemother       Date:  2017-05-01       Impact factor: 5.790

4.  Assessment of antibiotic prescription in acute urinary tract infections in adults.

Authors:  María A Martínez; Luis Inglada; Carlos Ochoa; José R Villagrasa
Journal:  J Infect       Date:  2006-07-10       Impact factor: 6.072

5.  Executive summary of the diagnosis and treatment of urinary tract infection: Guidelines of the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC).

Authors:  Marina de Cueto; Luis Aliaga; Juan-Ignacio Alós; Andres Canut; Ibai Los-Arcos; Jose Antonio Martínez; Jose Mensa; Vicente Pintado; Dolors Rodriguez-Pardo; Jose Ramon Yuste; Carles Pigrau
Journal:  Enferm Infecc Microbiol Clin       Date:  2016-12-23       Impact factor: 1.731

6.  Epidemiology, risk factors and comorbidity for urinary tract infections caused by extended-spectrum beta-lactamase (ESBL)-producing enterobacteria.

Authors:  L S Briongos-Figuero; T Gómez-Traveso; P Bachiller-Luque; M Domínguez-Gil González; A Gómez-Nieto; T Palacios-Martín; M González-Sagrado; A Dueñas-Laita; J L Pérez-Castrillón
Journal:  Int J Clin Pract       Date:  2012-09       Impact factor: 2.503

7.  Consequences of switching from a fixed 2 : 1 ratio of amoxicillin/clavulanate (CLSI) to a fixed concentration of clavulanate (EUCAST) for susceptibility testing of Escherichia coli.

Authors:  Maurine A Leverstein-van Hall; Karola Waar; Jan Muilwijk; James Cohen Stuart
Journal:  J Antimicrob Chemother       Date:  2013-06-13       Impact factor: 5.790

8.  Amoxicillin-clavulanic acid in treatment of urinary tract infection due to gram-negative bacteria resistant to penicillin.

Authors:  R Martinelli; A A Lopes; M M de Oliveira; H Rocha
Journal:  Antimicrob Agents Chemother       Date:  1981-12       Impact factor: 5.191
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.